Moreover, HER2/neu overexpression or amplification is associated with a poor prognosis, considering that it involves tumor invasion, lymph node metastasis, and recurrence (22–25). The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.